![Alison Bauerlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Bauerlein
Operationeel Directeur bij
SIGHT SCIENCES, INC.
Vermogen: 3 M $ op 31-05-2026
Profiel
Alison K.
Bauerlein was the founder of Inogen, Inc., founded in 2001, where the title held was Chief Financial Officer, Secretary & Treasurer from 2009 to 2014.
Current jobs include Director at Balance Ophthalmics, Inc. since 2024, Director at Koya Medical, Inc. since 2021, and Chief Operating Officer at Sight Sciences, Inc. starting in 2025.
Former jobs include Director at Active Life Scientific, Inc., Director at PureTech Health Plc, Independent Director at Gelesis Holdings, Inc. from 2022 to 2023, Director at Gelesis, Inc. from 2022 to 2023, Director at Equinox Ophthalmic, Inc. from 2020 to 2023, and Independent Director at Pear Therapeutics, Inc. from 2021 to 2024.
Education includes undergraduate studies at the University of California, Santa Barbara.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SIGHT SCIENCES, INC. 1,22% | 02-07-2026 | 664.709 ( 1,22% ) | 3 M $ | 31-05-2026 |
Actieve functies van Alison Bauerlein
| Bedrijven | Functie | Begin |
|---|---|---|
| SIGHT SCIENCES, INC. | Operationeel Directeur | 05-11-2025 |
Koya Medical, Inc.
 Koya Medical, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Bestuurslid | 01-01-2021 |
Eerdere bekende functies van Alison Bauerlein
| Bedrijven | Functie | Einde |
|---|---|---|
| PEAR THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-05-2024 |
| GELESIS HOLDINGS, INC. | Directeur/Bestuurslid | 30-10-2023 |
| GELESIS INC | Directeur/Bestuurslid | 01-10-2023 |
Equinox Ophthalmic, Inc.
 Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company, which provides cataract, corneal and glaucoma surgery services | Directeur/Bestuurslid | 01-03-2023 |
| INOGEN, INC. | Oprichter | 13-12-2021 |
Opleiding van Alison Bauerlein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Inogen, Inc.
 Inogen, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company | Health Technology |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Active Life Scientific, Inc.
 Active Life Scientific, Inc. Medical SpecialtiesHealth Technology Develops life science research and diagnostic tools | Health Technology |
Sight Sciences, Inc.
 Sight Sciences, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Equinox Ophthalmic, Inc.
Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company, which provides cataract, corneal and glaucoma surgery services | Commercial Services |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Koya Medical, Inc.
Koya Medical, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Pear Therapeutics, Inc.
 Pear Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a commercial stage healthcare company that develops software based medicines | Technology Services |
Gelesis Holdings, Inc.
 Gelesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops superabsorbent hydrogel therapeutics for chronic gastrointestinal, weight management and diabetes | Health Technology |
Kies MarketScreener 
